Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study
Authors
Keywords
-
Journal
LANCET INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-09-02
DOI
10.1016/s1473-3099(21)00460-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Attributes and predictors of long COVID
- (2021) Carole H. Sudre et al. NATURE MEDICINE
- SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
- (2021) Helen Ward et al. Nature Communications
- Systematic review of safety and efficacy of COVID-19 vaccines in patients with kidney disease
- (2021) Dorey A. Glenn et al. Kidney International Reports
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
- (2021) Cristina Menni et al. LANCET INFECTIOUS DISEASES
- Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
- (2021) Annemarie B Docherty et al. Lancet Respiratory Medicine
- Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app
- (2021) Carole H. Sudre et al. Science Advances
- Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
- (2021) Mark S Graham et al. Lancet Public Health
- Variants of Concern Are Overrepresented Among Postvaccination Breakthrough Infections of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Washington State
- (2021) Abbye E McEwen et al. CLINICAL INFECTIOUS DISEASES
- Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination
- (2021) Adeel A. Butt et al. JOURNAL OF INFECTION
- Spike-antibody waning after second dose of BNT162b2 or ChAdOx1
- (2021) Madhumita Shrotri et al. LANCET
- SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
- (2021) Aziz Sheikh et al. LANCET
- Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
- (2021) Talia Kustin et al. NATURE MEDICINE
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients
- (2021) Hector Rincon-Arevalo et al. Science Immunology
- Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study
- (2020) Simon de Lusignan et al. LANCET INFECTIOUS DISEASES
- Real-time tracking of self-reported symptoms to predict potential COVID-19
- (2020) Cristina Menni et al. NATURE MEDICINE
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study
- (2020) Long H Nguyen et al. Lancet Public Health
- The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study
- (2020) Jonathan Hewitt et al. Lancet Public Health
- Probable delirium is a presenting symptom of COVID-19 in frail, older adults: a cohort study of 322 hospitalised and 535 community-based older adults
- (2020) Maria Beatrice Zazzara et al. AGE AND AGEING
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- The UK has approved a COVID vaccine — here’s what scientists now want to know
- (2020) Heidi Ledford et al. NATURE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Geo-social gradients in predicted COVID-19 prevalence in Great Britain: results from 1 960 242 users of the COVID-19 Symptoms Study app
- (2020) Ruth C E Bowyer et al. THORAX
- Detecting COVID-19 infection hotspots in England using large-scale self-reported data from a mobile application: a prospective, observational study
- (2020) Thomas Varsavsky et al. Lancet Public Health
- Inverse probability weighting
- (2016) Mohammad Ali Mansournia et al. BMJ-British Medical Journal
- Inverse probability weighting
- (2016) Mohammad Ali Mansournia et al. BMJ-British Medical Journal
- Lifestyle‐Based Prediction Model for the Prevention of CVD: The Healthy Heart Score
- (2014) Stephanie E. Chiuve et al. Journal of the American Heart Association
- PRISMA-7: A case-finding tool to identify older adults with moderate to severe disabilities
- (2007) Michel Raîche et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More